Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review

Vaccine

Volumn 33, Issue 47, 2015, Pages 6420-6429

  Wilson, Rose J ^a   Paterson, Pauline ^a   Jarrett, Caitlin ^a   Larson, Heidi J ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Maternal immunisation; Maternal vaccination; Pregnancy; Racial ethnic minorities; Vaccine hesitancy

Indexed keywords

INFLUENZA VACCINE; TETANUS TOXOID;

ARTICLE; DEVELOPING COUNTRY; DRUG SAFETY; ETHNIC GROUP; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MATERNAL ATTITUDE; MATERNAL WELFARE; NORTH AMERICA; PREGNANCY; PRIORITY JOURNAL; REIMBURSEMENT; STAFF TRAINING; SYSTEMATIC REVIEW; VACCINATION; WORKLOAD; DISEASE TRANSMISSION; FEMALE; HEALTH; PATIENT ATTITUDE; PREVENTION AND CONTROL; UTILIZATION;

DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GLOBAL HEALTH; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; VACCINATION;

EID: 84943320902     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.046     Document Type: Article

References (97)

1. Open Working Group proposal for sustainable development goals 2015, United Nations Department of Economic and Social Affairs, Available from: https://sustainabledevelopment.un.org/sdgsproposal [20.5.15].
2. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K., et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014, 384(9953):1521-1528.
3. Public Health England Pertussis: the green book, Chapter 24 [PDF] 2015, Public Health England, England, Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/424448/Green_Book_Chapter_24_Pertussis_v2_0_April_2015.pdf [updated 28.4.15, 19.5.15].
4. McIntyre P.N W. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis 2009, 22:215-223.
5. WHO Children: reducing mortality 2014, Available from: http://www.who.int/mediacentre/factsheets/fs178/en/ [3.8.15].
6. Lawn J., Blencowe H., Oza S., You D., Lee A., Waiswa P., et al. Every newborn: progress, priorities, and potential beyond survival. Lancet 2014, 384(9938):189-205.
7. UNICEF data: monitoring the situation of children and women: current status+progress 2015, UNICEF, Available from: http://data.unicef.org/child-mortality/under-five [updated May 2015, 20.5.15].
8. Impatient Optimists Bill & Melinda Gates Foundation. Available from: [20.5.15] 2015. http://www.impatientoptimists.org/Posts/2015/03/Improving-Maternal-Immunization-Partners-Convene-to-Align-on-Way-Forward.
9. Mullooly J.P., Barker W.H., TF N. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986, 101:205-211.
10. Public Health England Seasonal influenza vaccine uptake amongst GP patients in England: provisional monthly data for 1 September 2014 to 30 November 2014 2014, Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/390281/2903322_SeasonalFlu_GP_Nov14_acc2.pdf [cited 1.12.14].
11. Public Health England Pertussis vaccination programme for pregnant women: vaccine coverage estimates in England September to December 2014 2015, Public Health England, UK, Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/408500/hpr0715_prtsss-vc.pdf [27.4.15].
12. Gall S., Poland G. A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy. Vaccine 2011, 29(51):9411-9413.
13. Wiley K., Massey P., Cooper S., Wood N., Quinn H., Leask J. Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine 2013, 31(37):3972-3978.
14. WHO. Maternal and neonatal tetanus (MNT) elimination; 2015. Avail-able from: http://www.who.int/immunization/diseases/MNTEinitiative/en/index1.html [30.4.15].
15. Blencowe H., Lawn J., Vandelaer J., Roper M., Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus (structured abstract). Int J Epidemiol 2010, 39(Suppl 1):i102-i109.
16. Blencowe H., Cousens S., Mullany L., Lee A., Kerber K., Wall S., et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health 2011, 11(Suppl 3):11.
17. Roper M., Vandelaer J., Gasse F. Maternal and neonatal tetanus. Lancet 2007, 370(9603):1947-1959.
18. Puopolo K. Current status of vaccine development for group B streptococcus. NeoReviews 2014, 15(10):e430-e438.
19. Schuchat A. Group B streptococcus. Lancet 1999, 353(9146):51-56.
20. Johri A., Paoletti L., Glaser P., Dua M., Sharma P., Grandi G., et al. Group B streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006, 4(12):932-942.
21. WHO WHO consultation on respiratory syncytial virus (RSV) vaccine development 2015, Available from: http://www.who.int/immunization/research/meetings_workshops/rsv_vaccine_development/en/ [3.8.15].
22. Rieder F., Steininger C. Cytomegalovirus vaccine: phase II clinical trial results. Clin Microbiol Infect 2014, Suppl 5:95-102.
23. Larson H., Jarrett C., Eckersberger E., Smith D., Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine 2014, 32(19):2150-2159.
24. WHO SAGE working group dealing with vaccine hesitancy (March 2012 to November 2014) 2012, Available from: http://www.who.int/immunization/sage/sage_wg_vaccine_hesitancy_apr12/en/ [19.5.15].
25. NHS The flu vaccination: winter 2014/15: who should have it and why UK: NHS 2014, Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/368079/PHE_8879_Flu_2014_A5_General_leaflet_14_.pdf [27.4.15].
26. NHS Whooping cough and pregnancy the safest way to protect yourself and your baby: what you need to know and do to help protect your baby 2014, NHS, UK, Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/323517/WhoopingCough_DL_flyer_2014_04_pdf [27.4.15].
27. Bulifon S., Tsatsaris V., Goffinet F., Mignon A., Batteux F., Delfraissy J.F., et al. Pandémie grippale A/H1N1v, grossesse et vaccination. Méd Maladies Infect 2010, 40(12):696-702.
28. Guthmann J., Bone A., J N., D L.-B. Insuffisance de couverture vaccinale grippale A(H1N1)2009 en population générale et dans les groupes à risque durant la pandémie 2009-2010 en France. BEHWeb 2010, 3:9-16.
29. Bish A., Yardley L., Nicoll A.S.M. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011, 29(38):6472-6484.
30. Yuen C.Y.M.T. Determinants of uptake of influenza vaccination among pregnant women - a systematic review. Vaccine 2014, 32(36):4602-4613.
31. Bish A., Yardley L., Nicoll A., Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011, 29(38):6472-6484.
32. Systematic literature studies: database searches vs. backward snowballing. ESEM'12 Proceedings of the ACM-IEEE International Symposium on Empirical Software Engineering and Measurement 2012, S. Jalali, C. Wohlin (Eds.).
33. Dickin K.L., Binchan R.K., Purdue S.E., Obinya E.A. Perceptions of neonatal tetanus and immunization during pregnancy: a report of focus group discussions in Kaduna, Nigeria. Int Quart Commun Health Educ 1991, 11(4):371-383.
34. Rahman M., Chen L.C., Chakraborty J. Use of tetanus toxoid for the prevention of neonatal tetanus II. Immunization acceptance among pregnant women in rural Bangladesh. Bull World Health Organ 1982, 60(2):269-277.
35. Buekens P., Tsui A., Kotelchuck M., Degraft-Johnson J. Tetanus immunization and prenatal care in developing countries. Int J Gynaecol Obstet 1995, 48(1):91-94.
36. Galazka A., Gasse F. The present status of tetanus and tetanus vaccination. Curr Top Microbiol Immunol 1995, 195:31-53.
37. Jamil K., Bhuiya A., Streatfield K., Chakrabarty N. The immunization programme in Bangladesh: impressive gains in coverage, but gaps remain. Health Policy Plann 1999, 14(1):49-58.
38. Gupta S., Keyl P. Effectiveness of prenatal tetanus toxoid immunization against neonatal tetanus in a rural area in India. Pediatr Infect Dis J 1998, 17(4):316-321.
39. Madico G., Salazar G., McDonald J., Checkley W., Calderón M., Verastegui M., et al. Rates of tetanus protection and transplacental tetanus antibody transfer in pregnant women from different socioeconomic groups in Peru. Clin Diagn Lab Immunol 1996, 3(6):753-755.
40. Roosihermiatie B., Nishiyama M., Nakae K. Factors associated with TT (tetanus toxoid) immunization among pregnant women, in Saparua, Maluku, Indonesia. Southeast Asian J Trop Med Public Health 2000, 31(1):91-95.
41. Maral I., Baykan Z., Aksakal F., Kayikcioglu F., Bumin M. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health 2001, 115(5):359-364.
42. Navaneetham K., Dharmalingam A. Utilization of maternal health care services in Southern India. Soc Sci Med 2002, 55(10):1849-1869.
43. Deming M., Roungou J., Kristiansen M., Heron I., Yango A., Guenengafo A., et al. Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ 2002, 80(9):696-703.
44. Ymba A., Perrey C. Acceptability of tetanus toxoid vaccine by pregnant women in two health centres in Abidjan (Ivory Coast). Vaccine 2003, 21(24):3497-3500.
45. Afridi N.K., Hatcher J., Mahmud S., Nanan D. Coverage and factors associated with tetanus toxoid vaccination status among females of reproductive age in Peshawar. J Coll Physicians Surg Pak 2005, 15(7):391-395.
46. Thind A. Determinants of tetanus toxoid immunization in pregnancy in rural Bihar. Trop Doct 2005, 35(2):75-77.
47. Housey M., Zhang F., Miller C., Lyon-Callo S., McFadden J., Garcia E., et al. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in medicaid - Michigan, 2011-2013. Morb Mortal Wkly Rep (MMWR) 2014, 63(38):839-842.
48. Varan A., Esteves-Jaramillo A., Richardson V., Esparza-Aguilar M., Cervantes-Powell P., Omer S.B. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine 2014, 32(7):785-792.
49. Bonville C.A., Cibula D.A., Domachowske J.B., Suryadevara M. Vaccine attitudes and practices among obstetric providers in New York State following the recommendation for pertussis vaccination during pregnancy. Hum Vaccin Immunother 2015, 11(3):713-718.
50. Campbell H., Van Hoek A.J., Bedford H., Craig L., Yeowell A.L., Yarwood J., et al. Attitudes to immunisation in pregnancy amongst women targeted by such programmes in the UK. BJM 2013, 23(8).
51. Kissin D.M., Power M.L., Kahn E.B., Williams J.L., Jamieson D.J., MacFarlane K., et al. Attitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy. Obstet Gynecol 2011, 118(5):1074-1080.
52. Leddy M.A., Anderson B.L., Power M.L., Gall S., Gonik B., Schulkin J. Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization. Obstet Gynecol Surv 2009, 64(12):823-829.
53. Power M.L., Leddy M.A., Anderson B.L., Gall S.A., Gonik B., Schulkin J. Obstetrician-gynecologists' practices and perceived knowledge regarding immunization. Am J Prev Med 2009, 37(3):231-234.
54. Beigi R.H., Switzer G.E., Meyn L.A. Acceptance of a pandemic avian influenza vaccine in pregnancy. J Reprod Med Obstet Gynecol 2009, 54(6):341-346.
55. Ishola D.J., Permalloo N., Cordery R., Anderson S. Midwives' influenza vaccine uptake and their views on vaccination of pregnant women. J Public Health (Oxf) 2013, 35(4):570-577.
56. Cassady D., Castaneda X., Ruelas M.R., Vostrejs M.M., Andrews T., Osorio L. Pandemics and vaccines: perceptions, reactions, and lessons learned from hard-to-reach Latinos and the H1N1 campaign. J Health Care Poor Underserved 2012, 23:1106-1122.
57. Hanquet G., Van Damme P., Brasseur D., De Cuyper X., Gregor S., Holmberg M., et al. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine 2011, 29(3):370-377.
58. Mersereau P.W., Layton C.M., Smith L.R., Kendrick J.S., Mitchell E.W., Amoozegar J.B., et al. Prenatal care providers and influenza prevention and treatment: lessons from the field. Matern Child Health J 2012, 16(2):479-485.
59. Link-Gelles R., Chamberlain A., Schulkin J., Ault K., Whitney E., Seib K., et al. Missed opportunities: a national survey of obstetricians about attitudes on maternal and infant immunization. Matern Child Health J 2012, 16(9):1743-1747.
60. Gyimah S.O., Takyi B.K., Addai I. Challenges to the reproductive-health needs of African women: on religion and maternal health utilization in Ghana. Soc Sci Med 2006, 62(12):2930-2944.
61. Ahluwalia, Jamieson D., D'Angelo D., Singleton J., Santibanez M., Euler G.G., et al. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women - 10 states, 2009-10 influenza season. CDC Morb Mort Wkly Rep (MMWR) 2010, 59(47):1541-1545.
62. Ball S., Donahue S., Izrael D., Walker D., Martonik R., DiSogra C., et al. Influenza vaccination coverage among pregnant women - United States, 2012-13 influenza season. CDC Morb Mort Wkly Rep (MMWR) 2013, 62(38):787-792.
63. Blondel B., Mahjoub N., Drewniak N., Launay O., Goffinet F. Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey. Vaccine 2012, 30(38):5661-5665.
64. Bödeker B., Walter D., Reiter S., Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine 2014, 32(33):4131-4139.
65. Ding H., Santibanez T.A., Jamieson D.J., Weinbaum C.M., Euler G.L., Grohskopf L.A., et al. Influenza vaccination coverage among pregnant women National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol 2011, 204(6 SUPPL):S96-S106.
66. Drees M., Tambourelli B., Denstman A., Zhang W., Zent R., McGraw P., et al. Sustained high influenza vaccination rates and decreased safety concerns among pregnant women during the 2010-2011 influenza season. Vaccine 2013, 31(2):362-366.
67. Eppes C., Wu A., You W., Cameron K.A., Garcia P., Grobman W. Barriers to influenza vaccination among pregnant women. Vaccine 2013, 31(27):2874-2878.
68. Freund R., Le Ray C., Charlier C., Avenell C., Truster V., Treluyer J.M., et al. Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study. PLoS ONE 2011, 6(6). Date of Publication: 2011.
69. Gorman J.R., Brewer N.T., Wang J.B., Chambers C.D. Theory-based predictors of influenza vaccination among pregnant women. Vaccine 2012, 31(1):213-218.
70. Lu P., Bridges C.B., Euler G.L., Singleton J.A. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 2008, 26(14):1786-1793.
71. Panda B., Stiller R., Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med 2010, 24(3):402-406.
72. Vitek W.S., Akers A., Meyn L.A., Switzer G.E., Lee B.Y., Beigi R.H. Vaccine eligibility and acceptance among ambulatory obstetric and gynecologic patients. Vaccine 2011, 29(11):2024-2028.
73. Chamberlain A., Seib K., Ault K., Orenstein W., Frew P., Malik F., et al. Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: a focus on vaccine hesitancy and perceptions of disease severity and vaccine safety. PLoS Curr Outbreaks 2015.
74. Drees M., Johnson O., Wong E., Stewart A., Ferisin S., Silverman P.R., et al. Acceptance of 2009 H1N1 influenza vaccine among pregnant women in Delaware. Am J Perinatol 2012, 29(4):289-294.
75. Fisher B.M., Scott J., Hart J., Winn V.D., Gibbs R.S., Lynch A.M. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol 2011, 204(Suppl 6):S107-S111.
76. Fridman D., Steinberg E., Azhar E., Weedon J., Wilson T.E., Minkoff H. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol 2011, 204(Suppl 6):S124-S127.
77. Goldfarb I., Panda B., Wylie B., Riley L. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol 2011, 204(6):S112-S115.
78. Kharbanda E.O., Vargas C.Y., Castano P.M., Lara M., Andres R., Stockwell M.S. Exploring pregnant women's views on influenza vaccination and educational text messages. Prev Med Int J Devoted Practice Theo 2011, 52(1):75-77.
79. Steelfisher G.K., Blendon R.J., Bekheit M.M., Mitchell E.W., Williams J., Lubell K., et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol 2011, 204(6):S116-S123.
80. Ganle J., Parker M., Fitzpatrick R., Otupiri E. Inequities in accessibility to and utilisation of maternal health services in Ghana after user-fee exemption: a descriptive study. Int J Equity Health 2014, 13:89.
81. Wong C.Y., Thomas N.J., Clarke M., Boros C., Tuckerman J., Marshall H.S. Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations. Hum Vaccin Immunother 2015, 11(5):1165-1172.
82. Henninger M.L., Irving S.A., Thompson M., Avalos L.A., Ball S.W., Shifflett P., et al. Factors associated with seasonal influenza vaccination in pregnant women. J Womens Health (Larchmt) 2015, 24(5):394-402.
83. Laenen J., Roelants M., Devlieger R., Vandermeulen C. Influenza and pertussis vaccination coverage in pregnant women. Vaccine 2015, 33(18):2125-2131.
84. Meharry P., Colson E., Grizas A., Stiller R., Vázquez M. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J 2013, 17(1):156-164.
85. Fabry P., Gagneur A., Pasquier J.C. Understanding pregnant womens intentions to have the A/H1N1 vaccine. Am J Obstet Gynecol 2011, 204:S247.
86. Ozer A., Arikan D.C., Kirecci E., Ekerbicer H.C. Status of pandemic influenza vaccination and factors affecting it in pregnant women in Kahramanmaras, an eastern Mediterranean city of Turkey. PLoS One 2010, 5(12):e14177.
87. Fabry P., Gagneur A., Pasquier J.C. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine 2011, 29(9):1824-1829.
88. Walker D., Ball S., Black R., Izrael D., Ding H., Euler G., et al. Influenza vaccination coverage among pregnant women-United States, 2010-11 influenza season. CDC Morb Mort Wkly Rep (MMWR) 2011, 60(32):1078-1082.
89. WHO. Maternal neonatal tetanus (MNT) elimination; 2015. Available from: http://www.who.int/immunization/diseases/MNTE initiative/en/ [20.5.15].
90. Luteijn J., Dolk H., Marnoch G. Differences in pandemic influenza vaccination policies for pregnant women in Europe. BMC Public Health 2011, 11(819).
91. Mirdamadi K., Einarson A. H1N1 and influenza viruses: why pregnant women might be hesitant to be vaccinated. Can Fam Physician 2011, 57(9):1003-1004.
92. Sakaguchi S., Weitzner B., Carey N., Bozzo P., Mirdamadi K., Samuel N., et al. Pregnant women's perception of risk with use of the H1N1 vaccine. J Obstet Gynaecol Can: JOGC 2011, 33(5):460-467.
93. Vaccine-preventable outbreaks: council on foreign relations, Available from: ; 2015 [30.4.15]. http://www.cfr.org/interactives/GH_Vaccine_Map/.
94. Liberia battles whooping cough outbreak: outbreak news today, Available from: ; 2015 [3.8.15]. http://outbreaknewstoday.com/liberia-battles-whooping-cough-outbreak-33731/.
95. Youngdahl K. NFID conference: challenges of maternal immunization: this history of vaccines blog 2013, Available from: http://www.historyofvaccines.org/content/blog/nfid-conference-challenges-maternal-immunization [19.5.15].
96. The report of the high-level panel of eminent persons on the post-2015 development. A new global partnership: eradicate poverty and transform economies through sustainable development 2013, UN, New York, Available from: http://www.un.org/sg/management/pdf/HLP_P2015_Report.pdf [20.5.15].
97. Thompson A. Communication training does not influence vaccine hesitancy. Clin Trials Update 2015, 314(4):331.